IN-VITRO MODULATION OF ANTI-DNA SECRETING PERIPHERAL-BLOOD MONONUCLEAR-CELLS OF LUPUS PATIENTS BY ANTIIDIOTYPIC ANTIBODY OF POOLED HUMAN INTRAVENOUS IMMUNE GLOBULIN

被引:10
作者
EVANS, M [1 ]
ABDOU, NI [1 ]
机构
[1] ST LUKES HOSP,IMMUNOL RES LAB,4400 WORNALL RD,KANSAS CITY,MO 64111
关键词
ANTI-DNA; INTRAVENOUS IMMUNE GLOBULIN; LUPUS;
D O I
10.1177/096120339300200607
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Anti-idiotypic antibody and its F(ab')2 fragments prepared from pooled normal human IgG had a partial inhibitory effect on the spontaneous in vitro secretion of anti-DNA antibodies from blood mononuclear cells of lupus patients. The inhibitory effect was specific for anti-DNA secretion as the anti-idiotype failed to inhibit the spontaneous secretion of anti-tetanus toxoid in the same culture supernatants. Non-anti-DNA IgG or its F(ab')2 fragments from pooled normal human IgG had less inhibitory effect on anti-DNA secretion than the purifieed anti-Id. In vitro polyclonal IgG secretion by lupus blood mononuclear cells was equally inhibited by both the anti-idiotype and the non-anti-DNA IgG of pooled normal human IgG. There was no correlation between the in vitro suppression of anti-DNA and that of total IgG or of anti-tetanus toxoid antibody. Pooled normal human IgG could have a potential beneficial effect in the therapy of systemic lupus erythematosus by inhibiting anti-DNA production via an anti-idiotypic mechanism.
引用
收藏
页码:371 / 375
页数:5
相关论文
共 21 条
[1]   ANTIIDIOTYPIC ANTIBODIES AGAINST ANTI-DNA ANTIBODIES IN SERA OF FAMILIES OF LUPUS PATIENTS [J].
ABDOU, NI ;
SUENAGA, R ;
HATFIELD, M ;
EVANS, M ;
HASSANEIN, KM .
JOURNAL OF CLINICAL IMMUNOLOGY, 1989, 9 (01) :16-21
[2]   THE NETWORK THEORY IN AUTOIMMUNITY - INVITRO MODULATION OF DNA-BINDING CELLS BY ANTIIDIOTYPIC ANTIBODY PRESENT IN INACTIVE LUPUS SERA [J].
ABDOU, NI ;
WALL, H ;
CLANCY, J .
JOURNAL OF CLINICAL IMMUNOLOGY, 1981, 1 (04) :234-240
[3]   NETWORK THEORY IN AUTOIMMUNITY - INVITRO SUPPRESSION OF SERUM ANTI-DNA ANTIBODY-BINDING TO DNA BY ANTI-IDIOTYPIC ANTIBODY IN SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
ABDOU, NI ;
WALL, H ;
LINDSLEY, HB ;
HALSEY, JF ;
SUZUKI, T .
JOURNAL OF CLINICAL INVESTIGATION, 1981, 67 (05) :1297-1304
[4]  
AKASHI K, 1990, J RHEUMATOL, V17, P375
[5]   MODULATION OF INVITRO SYNTHESIS OF IMMUNOGLOBULIN AND THE INDUCTION OF SUPPRESSOR ACTIVITY BY THERAPY WITH INTRAVENOUS IMMUNE GLOBULIN [J].
BALLOW, M ;
WHITE, W ;
DESBONNET, C .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1989, 84 (04) :595-602
[6]  
BALLOW M, 1991, CANCER, V68, P1430, DOI 10.1002/1097-0142(19910915)68:6+<1430::AID-CNCR2820681405>3.0.CO
[7]  
2-4
[8]   CLINICAL USES OF INTRAVENOUS IMMUNOGLOBULINS [J].
BERKMAN, SA ;
LEE, ML ;
GALE, RP .
ANNALS OF INTERNAL MEDICINE, 1990, 112 (04) :278-292
[9]  
CORVETTA A, 1989, CLIN EXP RHEUMATOL, V7, P295
[10]   NORMAL IMMUNOGLOBULIN-G (IGG) FOR THERAPEUTIC USE (INTRAVENOUS IG) CONTAIN ANTIIDIOTYPIC SPECIFICITIES AGAINST AN IMMUNODOMINANT, DISEASE-ASSOCIATED, CROSS-REACTIVE IDIOTYPE OF HUMAN ANTI THYROGLOBULIN AUTOANTIBODIES [J].
DIETRICH, G ;
KAZATCHKINE, MD .
JOURNAL OF CLINICAL INVESTIGATION, 1990, 85 (03) :620-625